PASCALE ADAM 4
4 · HEMISPHERX BIOPHARMA INC · Filed May 18, 2018
Insider Transaction Report
Form 4
Pascale Adam
Chief Accounting Officer
Transactions
- Award
Options to buy Common Stock
2018-05-16+83,334→ 83,334 totalExercise: $0.30From: 2018-05-16Exp: 2028-05-16→ Common Stock (83,334 underlying)
Footnotes (1)
- [F1]This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.